Medication possession ratio: Predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'Ivoire

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue SUPPL. 1, 2011, Pages

  Messou, Eugène ^a,b,c   Kouakou, Martial ^b   Gabillard, Delphine ^a,d   Gouessé, Patrice ^b   Koné, Mamadou ^b   Tchehy, Amah ^b   Losina, Elena ^c   Freedberg, Kenneth A ^c   Dri Yoman, Thérèse N' ^a,b   Anzian, Amani ^a,b   Toure, Siaka ^a,b   Anglaret, Xavier ^a,d  

^a Programme PACCI CIRBA   (Côte d’Ivoire)

^b ACONDA   (Côte d’Ivoire)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d INSERM   (France)

Author keywords

adults; cART; lost to follow up; medication possession ratio; sub Saharan Africa

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COTE D'IVOIRE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; COTE D'IVOIRE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 79959760451     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182208003     Document Type: Article

References (25)

1. WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Available at: http://www.who.int/ hiv/pub/2010progressreport/en/index.html. Accessed May 16, 2011.
2. Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010;24:563-572.
3. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-567. (Pubitemid 351931216)
4. Mutevedzi PC, Lessells RJ, Heller T, et al. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ. 2010; 88:593-600.
5. Ekouevi DK, Balestre E, Ba-Gomis FO, et al. Low retention of HIVinfected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health. 2010;15(suppl 1):34-42.
6. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ. 2007;85:550-554. (Pubitemid 47041634)
7. Dalal RP, Macphail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;47: 101-107. (Pubitemid 351619376)
8. Bisson GP, Gaolathe T, Gross R, et al. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One. 2008; 3:e1725.
9. Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIVinfected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2004;35:320-323. (Pubitemid 38280660)
10. Geng EH, Glidden DV, Emenyonu N, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health. 2010;15(suppl 1):63-69.
11. Maskew M, MacPhail P, Menezes C, et al. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007;97:853-857. (Pubitemid 47542654)
12. Weigel R, Hochgesang M, Brinkhof M, et al. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC Infect Dis. 2011;11: .31. E-pub ahead of print.
13. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Med. 2007;4: 1691-1701. (Pubitemid 350035458)
14. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(suppl 1):1-15.
15. Karcher H, Omondi A, Odera J, et al. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12:687-694. (Pubitemid 46625297)
16. Ochieng-Ooko V, Ochieng D, Sidle JE, et al. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010;88:681-688.
17. Losina E, Toure H, Uhler LM, et al. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal. PLoS Med. 2009;6:e1000173.
18. Messou E, Chaix M, Gabillard D, et al. Association between medication possession ratio, virologic failure and drug resistance in HIV-1 infected adults on antiretroviral therapy in Cô te d'Ivoire. J Acquir Immune Defic Syndr. 2011;56:356-364.
19. Messou E, Anglaret X, Duvignac J, et al. Antiretroviral treatment changes in adults from Cote d'Ivoire: the roles of tuberculosis and pregnancy. AIDS. 2010;24:93-99.
20. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2006 revision. Available at: http://www.who.int/hiv/pub/guidelines/ artadultguidelines.pdf. Accessed May 16, 2011.
21. Decroo T, Telfer B, Biot M, et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. J Acquir Immune Defic Syndr. 2011;56:e39-e44.
22. Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS. 2008;22:873-882. (Pubitemid 351563837)
23. Palombi L, Marazzi MC, Guidotti G, et al. Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviraltreated patients in sub-Saharan African Sites with comprehensive monitoring availability. Clin Infect Dis. 2009;48:115-122.
24. Bisson GP, Gross R, Bellamy S, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5:e109.
25. McMahon J, Jordan M, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011;52: 493-506.